Kristen Mills

Assistant Professor, Mechanical Aerospace and Nuclear Engineering Rensselaer Polytechnic Institute

  • Troy NY

Biomechanics of tumor growth, tumor cell-matrix interactions

Contact

Rensselaer Polytechnic Institute

View more experts managed by Rensselaer Polytechnic Institute

Areas of Expertise

Cell and tissue biomechanics
Experimental mechanics of materials
Development of in vitro models

Biography

Kristen Mills, an assistant professor of mechanical engineering at Rensselaer Polytechnic Institute, studies the mechanics of cancer and tumor cell invasion, migration, and interactions with the extracellular matrix. Her lab develops new models that mimic aspects of the mechanical environment within the body, providing new insight into solid tumor development and metastasis. Mills earned her bachelors of science in mechanical engineering from the University of California, San Diego, in 1999 before receiving her Ph.D. in mechanical engineering from the University of Michigan in 2008. She was a postdoctoral researcher in the Department of New Materials and Biosystem at the Max Planck Institute for Intelligent Systems, and a lecturer in advanced materials at the University of Ulm, before joining the Rensselaer faculty. Mills received a National Science Foundation Faculty Early Career Development Program (CAREER) Award in 2019, as well as a Department of Defense CDMRP Neurofibromatosis Research Program New Investigator Award.

Media

Education

University of California San Diego

B.S.

Mechanical Engineering

1999

University of Michigan

Ph.D.

Mechanical Engineering

2008

Max Planck Institute for Intelligent Systems

Postdoctoral Researcher

2014

Media Appearances

RPI researchers working to unlock secrets that help fight cancer

WNYT  tv

2021-01-26

Mechanical engineering and biology are coming together in Troy with the potential to save lives.

View More

Articles

Growth of tumor emboli within a vessel model reveals dependence on the magnitude of mechanical constraint

Integrative Biology

Jonathan Kulwatno, Jamie Gearhart, Xiangyu Gong, Nora Herzog, Matthew Getzin, Mihaela Skobe, and Kristen L. Mills

2021-01-14

Tumor emboli—aggregates of tumor cells within vessels—pose a clinical challenge as they are associated with increased metastasis and tumor recurrence. When growing within a vessel, tumor emboli are subject to a unique mechanical constraint provided by the tubular geometry of the vessel. Current models of tumor emboli use unconstrained multicellular tumor spheroids, which neglect this mechanical interplay. Here, we modeled a lymphatic vessel as a 200 μm-diameter channel in either a stiff or soft, bioinert agarose matrix to create a vessel-like constraint model (VLCM), and we modeled colon or breast cancer tumor emboli with aggregates of HCT116 or SUM149PT cells, respectively. The stiff matrix VLCM constrained the tumor emboli to the cylindrical channel, which led to continuous growth of the emboli, in contrast to the growth rate reduction that unconstrained spheroids exhibit. Emboli morphology in the soft matrix VLCM, however, was dependent on the magnitude of mechanical mismatch between the matrix and the cell aggregates. In general, when the elastic modulus of the matrix of the VLCM was greater than the emboli (EVLCM/Eemb > 1), the emboli were constrained to grow within the channel, and when the elastic modulus of the matrix was less than the emboli (0 < EVLCM/Eemb < 1), the emboli bulged into the matrix. Due to a large difference in myosin II expression between the cell lines, we hypothesized that tumor cell aggregate stiffness is an indicator of cellular force-generating capability. Inhibitors of myosin-related force generation decreased the elastic modulus and/or increased the stress relaxation of the tumor cell aggregates, effectively increasing the mechanical mismatch. The increased mechanical mismatch after drug treatment was correlated with increased confinement of tumor emboli growth along the channel, which may translate to increased tumor burden due to the increased tumor volume within the diffusion distance of nutrients and oxygen.

View more

An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma In Situ Progression

Tissue Engineering Part A

Jonathan Kulwatno, Xiangyu Gong, Rebecca DeVaux, Jason I Herschkowitz, and Kristen L Mills

2021-03-01

Ductal carcinoma in situ (DCIS) is a precancerous stage breast cancer, where abnormal cells are contained within the duct, but have not invaded into the surrounding tissue. However, only 30–40% of DCIS cases are likely to progress into an invasive ductal carcinoma (IDC), while the remainder are innocuous. Since little is known about what contributes to the transition from DCIS to IDC, clinicians and patients tend to opt for treatment, leading to concerns of overdiagnosis and overtreatment. In vitro models are currently being used to probe how DCIS transitions into IDC, but many models do not take into consideration the macroscopic tissue architecture and the biomechanical properties of the microenvironment. In this study, we modeled an organotypic mammary duct as a channel molded in a collagen matrix and lined with basement membrane. By adjusting the concentration of collagen (4 and 8 mg/mL), we modulated the stiffness and morphological properties of the matrix and examined how an assortment of breast cells, including the isogenic MCF10 series that spans the range from healthy to aggressive, behaved within our model. We observed distinct characteristics of breast cancer progression such as hyperplasia and invasion. Normal mammary epithelial cells (MCF10A) formed a single-cell layer on the lumen surface, whereas the most aggressive (MCF10CA1) were several cell layers thick. The model captured collagen concentration-dependent protrusive behaviors by the MCF10A and MCF10CA1 cells, as well as a known invasive cell line (MDA-MB-231). The MCF10A and MCF10CA1 cells extended protrusions into the lower collagen concentration matrix, while the MDA-MB-231 cells fully invaded matrices of either collagen concentration but to a greater distance in the higher collagen concentration matrix. Our results show that the model can recapitulate different stages of breast cancer progression and that the MCF10 series is adaptable to physiologically relevant in vitro studies, demonstrating the potential of both the model and cell lines to elucidate key factors that may contribute to understanding the transition from DCIS to IDC.

View more

Rapid fabrication of collagen bundles mimicking tumor-associated collagen architectures

Acta Biomaterialia

Xiangyu Gong, Jonathan Kulwatno, and Kristen Mills

2020-05-01

Stromal collagen is upregulated surrounding a solid tumor and presents as dense, thick, linearized, and aligned bundles. The collagen bundles are continually remodeled during tumor progression, and their orientation with respect to the tumor boundary has been correlated with invasive state. Currently, reconstituted-collagen gels are the standard in vitro tumor cell-extracellular matrix interaction model. The reticular, dense, and isotropic nanofiber (~900 nm-diameter, on average) gels do not, however, recapitulate the in vivo structural features of collagen bundling and alignment. Here, we present a rapid and simple method to fabricate bundles of collagen type I, whose average thickness may be varied between about 4 μm and 9 μm dependent upon diluent temperature and ionic strength. The durability and versatility of the collagen bundles was demonstrated with their incorporation into two in vitro models where the thickness and alignment of the collagen bundles resembled various in vivo arrangements. First, collagen bundles aligned by a microfluidic device elicited cancer cell contact guidance and enhanced their directional migration. Second, the presence of the collagen bundles in a bio-inert agarose hydrogel was shown to provide a route for cancer cell outgrowth. The unique structural features of the collagen bundles advance the physiological relevance of in vitro collagen-based tumor models for accurately capturing tumor cell-extracellular matrix interactions.

View more

Show All +